The Weight-Loss Drug Battlefield: Ozempic and Its Rivals Spark Price Wars and Promise New Access As Novo Nordisk slashes prices for its blockbuster medications, patients and insurers brace for a shifting landscape of accessibility and affordability in the booming weight-loss market. The highly anticipated and rapidly expanding market for weight-loss medications is entering a new,…